Status:
RECRUITING
Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA
Lead Sponsor:
CHU de Reims
Conditions:
Sickle Cells Patients
Eligibility:
All Genders
2-18 years
Brief Summary
Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis (Limit : 5000 characters) The sickle cells anemia is a monogenic disease linked to the ...
Eligibility Criteria
Inclusion
- Sickle cells patient
- Age between 2 and 18 years old
- Being affiliated with social security
Exclusion
- Having a neurological defect prior to the study
- Being against the collection of blood or data
Key Trial Info
Start Date :
November 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT06581900
Start Date
November 27 2024
End Date
December 1 2026
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092